Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Publisher Correction: Synthesis of Saccharumoside-B analogue with potential of antiproliferative and pro-apoptotic activities.

Rayavarapu S, Yarla NS, Kadiri SK, Bishayee A, Vidavalur S, Tadikonda R, Basha M, Pidugu VR, Dowluru KSVGK, Lakappa DB, Kamal MA, Ashraf GM, Tarasov VV, Chubarev VN, Klochkov SG, Barreto GE, Bachurin SO, Aliev G.

Sci Rep. 2020 Jan 8;10(1):185. doi: 10.1038/s41598-019-57392-w.

2.

AMP-activated protein kinase signaling regulated expression of urea cycle enzymes in response to changes in dietary protein intake.

Heibel SK, McGuire PJ, Haskins N, Majumdar HD, Rayavarapu S, Nagaraju K, Hathout Y, Brown K, Tuchman M, Caldovic L.

J Inherit Metab Dis. 2019 Nov;42(6):1088-1096. doi: 10.1002/jimd.12133. Epub 2019 Aug 1.

PMID:
31177541
3.

A modular approach towards functionalized highly stable self-complementary quadruple hydrogen bonded systems.

Rayavarapu S, Kheria S, Shinde DR, Gonnade RG, Sanjayan GJ.

Org Biomol Chem. 2017 Dec 6;15(47):10087-10094. doi: 10.1039/c7ob02358h.

PMID:
29170774
4.

Synthesis of Saccharumoside-B analogue with potential of antiproliferative and pro-apoptotic activities.

Rayavarapu S, Yarla NS, Kadiri SK, Bishayee A, Vidavalur S, Tadikonda R, Basha M, Pidugu VR, Dowluru KSVGK, Lakappa DB, Kamal MA, Md Ashraf G, Tarasov VV, Chubarev VN, Klochkov SG, Barreto GE, Bachurin SO, Aliev G.

Sci Rep. 2017 Aug 16;7(1):8309. doi: 10.1038/s41598-017-05832-w. Erratum in: Sci Rep. 2020 Jan 8;10(1):185.

5.

Coumarin-Appended Stable Fluorescent Self-Complementary Quadruple-Hydrogen-Bonded Molecular Duplexes.

Kheria S, Rayavarapu S, Kotmale AS, Shinde DR, Gonnade RG, Sanjayan GJ.

J Org Chem. 2017 Jun 16;82(12):6403-6408. doi: 10.1021/acs.joc.7b01249. Epub 2017 Jun 6.

PMID:
28558211
6.

Three in one: prototropy-free highly stable AADD-type self-complementary quadruple hydrogen-bonded molecular duplexes with a built-in fluorophore.

Kheria S, Rayavarapu S, Kotmale AS, Sanjayan GJ.

Chem Commun (Camb). 2017 Feb 28;53(18):2689-2692. doi: 10.1039/c6cc09478c.

PMID:
28197572
7.

Triazine-Based Highly Stable AADD-Type Self-Complementary Quadruple Hydrogen-Bonded Systems Devoid of Prototropy.

Kheria S, Rayavarapu S, Kotmale AS, Gonnade RG, Sanjayan GJ.

Chemistry. 2017 Jan 18;23(4):783-787. doi: 10.1002/chem.201605208. Epub 2016 Dec 12.

PMID:
27862470
8.

Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy.

Vila MC, Rayavarapu S, Hogarth MW, Van der Meulen JH, Horn A, Defour A, Takeda S, Brown KJ, Hathout Y, Nagaraju K, Jaiswal JK.

Cell Death Differ. 2017 Feb;24(2):330-342. doi: 10.1038/cdd.2016.127. Epub 2016 Nov 11.

9.

Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients.

Nagaraju K, Ghimbovschi S, Rayavarapu S, Phadke A, Rider LG, Hoffman EP, Miller FW.

Rheumatology (Oxford). 2016 Sep;55(9):1673-80. doi: 10.1093/rheumatology/kew213. Epub 2016 May 23.

10.

Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.

Benny Klimek ME, Sali A, Rayavarapu S, Van der Meulen JH, Nagaraju K.

PLoS One. 2016 May 23;11(5):e0155944. doi: 10.1371/journal.pone.0155944. eCollection 2016.

11.

The use of proteomic analysis to study trafficking defects in axons.

Fu X, Brown KJ, Rayavarapu S, Nagaraju K, Liu JS.

Methods Cell Biol. 2016;131:151-62. doi: 10.1016/bs.mcb.2015.06.009. Epub 2015 Sep 2.

PMID:
26794512
12.

Elusive sources of variability of dystrophin rescue by exon skipping.

Vila MC, Klimek MB, Novak JS, Rayavarapu S, Uaesoontrachoon K, Boehler JF, Fiorillo AA, Hogarth MW, Zhang A, Shaughnessy C, Gordish-Dressman H, Burki U, Straub V, Lu QL, Partridge TA, Brown KJ, Hathout Y, van den Anker J, Hoffman EP, Nagaraju K.

Skelet Muscle. 2015 Dec 1;5:44. doi: 10.1186/s13395-015-0070-6. eCollection 2015.

13.

Effect of genetic background on the dystrophic phenotype in mdx mice.

Coley WD, Bogdanik L, Vila MC, Yu Q, Van Der Meulen JH, Rayavarapu S, Novak JS, Nearing M, Quinn JL, Saunders A, Dolan C, Andrews W, Lammert C, Austin A, Partridge TA, Cox GA, Lutz C, Nagaraju K.

Hum Mol Genet. 2016 Jan 1;25(1):130-45. doi: 10.1093/hmg/ddv460. Epub 2015 Nov 12.

14.

The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse.

Zhang A, Uaesoontrachoon K, Shaughnessy C, Das JR, Rayavarapu S, Brown KJ, Ray PE, Nagaraju K, van den Anker JN, Hoffman EP, Hathout Y.

Toxicol Rep. 2015;2:838-849.

15.

Inhibition of inflammation with celastrol fails to improve muscle function in dysferlin-deficient A/J mice.

Dillingham BC, Benny Klimek ME, Gernapudi R, Rayavarapu S, Gallardo E, Van der Meulen JH, Jordan S, Ampong B, Gordish-Dressman H, Spurney CF, Nagaraju K.

J Neurol Sci. 2015 Sep 15;356(1-2):157-62. doi: 10.1016/j.jns.2015.06.042. Epub 2015 Jun 24.

16.

Comparative Risk Assessment of Formulation Changes in Generic Drug Products: A Pharmacology/Toxicology Perspective.

Rayavarapu S, Braithwaite E, Dorsam R, Osterhout J, Furlong LA, Shetty D, Peters JR.

Toxicol Sci. 2015 Jul;146(1):2-10. doi: 10.1093/toxsci/kfv074. Review.

PMID:
26101235
17.

Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.

Hathout Y, Marathi RL, Rayavarapu S, Zhang A, Brown KJ, Seol H, Gordish-Dressman H, Cirak S, Bello L, Nagaraju K, Partridge T, Hoffman EP, Takeda S, Mah JK, Henricson E, McDonald C.

Hum Mol Genet. 2014 Dec 15;23(24):6458-69. doi: 10.1093/hmg/ddu366. Epub 2014 Jul 15.

18.

Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle.

Henriques-Pons A, Yu Q, Rayavarapu S, Cohen TV, Ampong B, Cha HJ, Jahnke V, Van der Meulen J, Wang D, Jiang W, Kandimalla ER, Agrawal S, Spurney CF, Nagaraju K.

Hum Mol Genet. 2014 May 15;23(10):2604-17. doi: 10.1093/hmg/ddt656. Epub 2013 Dec 23.

19.

Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target.

Rayavarapu S, Coley W, Van der Meulen JH, Cakir E, Tappeta K, Kinder TB, Dillingham BC, Brown KJ, Hathout Y, Nagaraju K.

Arthritis Rheum. 2013 Dec;65(12):3248-58. doi: 10.1002/art.38180.

20.

A synthetic zipper peptide motif orchestrated via co-operative interplay of hydrogen bonding, aromatic stacking, and backbone chirality.

Nair RV, Kheria S, Rayavarapu S, Kotmale AS, Jagadeesh B, Gonnade RG, Puranik VG, Rajamohanan PR, Sanjayan GJ.

J Am Chem Soc. 2013 Aug 7;135(31):11477-80. doi: 10.1021/ja405455g. Epub 2013 Jul 26.

PMID:
23865816
21.

The effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A/J mice: role of endogenous TLR ligands.

Uaesoontrachoon K, Cha HJ, Ampong B, Sali A, Vandermeulen J, Wei B, Creeden B, Huynh T, Quinn J, Tatem K, Rayavarapu S, Hoffman EP, Nagaraju K.

J Pathol. 2013 Oct;231(2):199-209. doi: 10.1002/path.4207.

22.

Daily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositis.

Coley W, Rayavarapu S, van der Meulen JH, Duba AS, Nagaraju K.

PLoS One. 2013 Jun 13;8(6):e65970. doi: 10.1371/journal.pone.0065970. Print 2013.

23.

Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy.

Yu Q, Sali A, Van der Meulen J, Creeden BK, Gordish-Dressman H, Rutkowski A, Rayavarapu S, Uaesoontrachoon K, Huynh T, Nagaraju K, Spurney CF.

PLoS One. 2013 Jun 6;8(6):e65468. doi: 10.1371/journal.pone.0065468. Print 2013.

24.

Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness.

Rayavarapu S, Coley W, Kinder TB, Nagaraju K.

Skelet Muscle. 2013 Jun 7;3(1):13. doi: 10.1186/2044-5040-3-13.

25.

Accurate Quantitation of Dystrophin Protein in Human Skeletal Muscle Using Mass Spectrometry.

Brown KJ, Marathi R, Fiorillo AA, Ciccimaro EF, Sharma S, Rowlands DS, Rayavarapu S, Nagaraju K, Hoffman EP, Hathout Y.

J Bioanal Biomed. 2012 Dec 18;Suppl 7. pii: 001.

26.

Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.

Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, Grodish-Dressman H, Jaiswal JK, Hoffman EP, Brown KJ, Hathout Y, Nagaraju K.

Mol Cell Proteomics. 2013 May;12(5):1061-73. doi: 10.1074/mcp.M112.023127. Epub 2013 Jan 7.

27.

The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.

Coley W, Rayavarapu S, Pandey GS, Sabina RL, Van der Meulen JH, Ampong B, Wortmann RL, Rawat R, Nagaraju K.

Arthritis Rheum. 2012 Nov;64(11):3750-9. doi: 10.1002/art.34625.

28.

Use of quantitative membrane proteomics identifies a novel role of mitochondria in healing injured muscles.

Sharma N, Medikayala S, Defour A, Rayavarapu S, Brown KJ, Hathout Y, Jaiswal JK.

J Biol Chem. 2012 Aug 31;287(36):30455-67. doi: 10.1074/jbc.M112.354415. Epub 2012 Jul 9.

29.

Δ-9,11 modification of glucocorticoids dissociates nuclear factor-κB inhibitory efficacy from glucocorticoid response element-associated side effects.

Baudy AR, Reeves EK, Damsker JM, Heier C, Garvin LM, Dillingham BC, McCall J, Rayavarapu S, Wang Z, Vandermeulen JH, Sali A, Jahnke V, Duguez S, DuBois D, Rose MC, Nagaraju K, Hoffman EP.

J Pharmacol Exp Ther. 2012 Oct;343(1):225-32. doi: 10.1124/jpet.112.194340. Epub 2012 Jun 28.

30.

Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies.

Coley W, Rayavarapu S, Nagaraju K.

Arthritis Res Ther. 2012 Apr 27;14(2):209. doi: 10.1186/ar3791. Review.

31.

Endoplasmic reticulum stress in skeletal muscle homeostasis and disease.

Rayavarapu S, Coley W, Nagaraju K.

Curr Rheumatol Rep. 2012 Jun;14(3):238-43. doi: 10.1007/s11926-012-0247-5. Review.

32.

Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trial.

Escolar DM, Zimmerman A, Bertorini T, Clemens PR, Connolly AM, Mesa L, Gorni K, Kornberg A, Kolski H, Kuntz N, Nevo Y, Tesi-Rocha C, Nagaraju K, Rayavarapu S, Hache LP, Mayhew JE, Florence J, Hu F, Arrieta A, Henricson E, Leshner RT, Mah JK.

Neurology. 2012 Mar 20;78(12):904-13. doi: 10.1212/WNL.0b013e31824c46be. Epub 2012 Mar 7.

33.

Glucocorticoid analogues: potential therapeutic alternatives for treating inflammatory muscle diseases.

Reeves EK, Rayavarapu S, Damsker JM, Nagaraju K.

Endocr Metab Immune Disord Drug Targets. 2012 Mar;12(1):95-103. Review.

PMID:
22214335
34.

An update on pathogenic mechanisms of inflammatory myopathies.

Rayavarapu S, Coley W, Nagaraju K.

Curr Opin Rheumatol. 2011 Nov;23(6):579-84. doi: 10.1097/BOR.0b013e32834b41d2. Review.

PMID:
21960036
35.

Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice.

Spurney CF, Sali A, Guerron AD, Iantorno M, Yu Q, Gordish-Dressman H, Rayavarapu S, van der Meulen J, Hoffman EP, Nagaraju K.

J Cardiovasc Pharmacol Ther. 2011 Mar;16(1):87-95. doi: 10.1177/1074248410381757.

36.

Measurement of activation of the endoplasmic reticulum stress response in autoimmune myositis.

Alger HM, Rayavarapu S, Nagaraju K.

Methods Enzymol. 2011;489:207-25. doi: 10.1016/B978-0-12-385116-1.00012-1.

PMID:
21266232
37.

Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.

Rayavarapu S, Van der Meulen JH, Gordish-Dressman H, Hoffman EP, Nagaraju K, Knoblach SM.

PLoS One. 2010 Sep 24;5(9):e12981. doi: 10.1371/journal.pone.0012981.

38.

Acquisition of immunity to Eimeria maxima in newly hatched chickens reared on new or reused litter.

Chapman HD, Rayavarapu S.

Avian Pathol. 2007 Aug;36(4):319-23.

PMID:
17620179

Supplemental Content

Loading ...
Support Center